The European Union Drugs Agency (EUDA) today released its Consolidated Annual Activity Report 2025, capturing the agency’s key achievements, governance activities and organisational developments during the first full year of operation under its expanded mandate.
Structured around three core areas — health, security and business transformation — the report outlines how the EUDA strengthened Europe’s preparedness on drugs through enhanced monitoring, new alert and threat assessment tools, professional training, and closer cooperation with European and international partners.
A central focus in 2025 was staying ahead of emerging drug challenges. During the year, the agency launched its European Drug Alert System (EDAS) to improve preparedness and response to serious health, social, safety and security drug-related risks across Europe. This complements the EU Early Warning System which formally notified 50 new psychoactive substances in 2025. The agency also operationalised the new EUDA Threat Assessment System (ETAS), releasing a pilot threat assessment on highly potent synthetic opioids in the Baltic region. It continued to develop its Network of forensic and toxicological laboratories and launched a new analytical reference standards kit to support the identification of emerging substances. At the request of the European Commission, the agency also delivered nine precursor assessments, addressing cross-border risks linked to precursors used in synthetic drug production.
Supporting countries in strengthening prevention, treatment and harm reduction responses remained central to the agency’s work. New and updated miniguides, on harm-reduction equipment and cannabis, were released through the European guide on health and social responses to drug problems, while work continued to support progress towards the World Health Organization’s hepatitis elimination targets. The EUDA also contributed to the joint EUDA–ECDC European Toolkit for the Elimination of Viral Hepatitis in Prisons (EuroHePP), aimed at improving care in custodial settings.
Throughout the year, the EUDA invested in professional capacity-building through training, webinars and technical guidance, while providing scientific and technical expertise to support European and international drug policy discussions. This included contributions to the new EU Drugs Strategy and the EU Action Plan against drug trafficking.
International cooperation remained a cornerstone of the agency’s activities, with strengthened partnerships across Europe and beyond, including the adoption of two new frameworks. The first of these, the EUDA International Cooperation Framework, sets out the agency’s vision and priorities for enhancing global collaboration on drug-related challenges. The second, the Reitox Alliance Operating Framework, establishes a renewed partnership aligning the network’s activities with the agency’s expanded mandate.
Communication and outreach were further expanded through digital campaigns, media engagement and the rollout of the EUDA Communication Strategy 2025–2028 and visual identity guidance. In 2025, the agency published 35 scientific and institutional publications and authored or co‑authored 24 scientific articles and book chapters. The year also marked the 30th edition of the European Drug Report and the European School Survey Project on Alcohol and Other Drugs (ESPAD).
2025 was a year of organisational transformation. The agency launched a multi-year Organisational Development Plan aimed at aligning governance, digitalisation, communication and service delivery with its expanded responsibilities. It also initiated a five-year digital transformation programme to strengthen cybersecurity, resilience and digital services. At the same time, the EUDA advanced its foresight activities, including the publication of futures scenarios exploring drugs and addiction in Europe by 2040.
In June, the appointment of Dr Lorraine Nolan as the next EUDA Executive Director opened a new leadership chapter for the agency. Dr Nolan took up her functions on 1 January 2026, succeeding Alexis Goosdeel after 10 years leading the agency.
The report is accompanied by a snapshot of EUDA 2025 activities.
